A carregar...
Safety and efficacy of leflunomide in primary Sjögren's syndrome: a phase II pilot study
BACKGROUND: For invalidating symptoms in primary Sjögren's syndrome (pSS), there is still a need for easy‐to‐administer, cost‐effective and well‐tolerated systemic treatment. Leflunomide (LEF) is structurally unrelated to other immunomodulatory drugs and might be efficacious in pSS, given its c...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Group
2007
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1954693/ https://ncbi.nlm.nih.gov/pubmed/17223657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.060905 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|